Prognostic Value of Hemoglobin A1C Levels in Patients With Diabetes Mellitus Undergoing Percutaneous Coronary Intervention With Stent Implantation

American Journal of Cardiology

Volumn 104, Issue 1, 2009, Pages 41-45

  Lemesle, Gilles ^a   Bonello, Laurent ^a   de Labriolle, Axel ^a   Maluenda, Gabriel ^a   Syed, Asmir I ^a   Collins, Sara D ^a   Ben Dor, Itsik ^a   Torguson, Rebecca ^a   Kaneshige, Kimberly ^a   Xue, Zhenyi ^a   Suddath, William O ^a   Satler, Lowell F ^a   Kent, Kenneth M ^a   Lindsay, Joseph ^a   Pichard, Augusto D ^a   Waksman, Ron ^a  

^a WASHINGTON HOSPITAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HEMOGLOBIN A1C; INSULIN;

ACUTE HEART INFARCTION; ADULT; AGE DISTRIBUTION; AGED; ARTICLE; BODY MASS; CARDIOGENIC SHOCK; CARDIOVASCULAR DISEASE; CONGESTIVE HEART FAILURE; CONTROLLED STUDY; CORONARY ARTERY DISEASE; CORONARY STENT; DEATH; DIABETES MELLITUS; DIABETIC PATIENT; FEMALE; GLYCEMIC CONTROL; HEART INFARCTION; HEMOGLOBIN BLOOD LEVEL; HUMAN; KIDNEY FAILURE; MAJOR CLINICAL STUDY; MALE; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; PROGNOSIS; REVASCULARIZATION; STABLE ANGINA PECTORIS; UNSTABLE ANGINA PECTORIS;

AGED; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; COHORT STUDIES; CONFIDENCE INTERVALS; CORONARY ANGIOGRAPHY; CORONARY ARTERY DISEASE; DIABETES COMPLICATIONS; DRUG-ELUTING STENTS; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; REGISTRIES; RETROSPECTIVE STUDIES;

EID: 67649359495     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjcard.2009.02.060     Document Type: Article

References (24)

1. Selvin E., Marinopoulos S., Berkenblit G., Rami T., Brancati F.L., Powe N.R., and Golden S.H. Meta-analysis: glycosylated hemoglobin and cardiovascular disease in diabetes mellitus. Ann Intern Med 141 (2004) 421-431
2. Gasior M., Pres D., Stasik-Pres G., Lech P., Gierlotka M., Hawranek M., Wilczek K., Szygula-Jurkiewicz B., Lekston A., Kalarus Z., Strojek K., Gumprecht J., and Polonski L. Effect of blood glucose levels on prognosis in acute myocardial infarction in patients with and without diabetes, undergoing percutaneous coronary intervention. Cardiol J 15 (2008) 422-430
3. Ishihara M., Kagawa E., Inoue I., Kawagoe T., Shimatani Y., Kurisu S., Nakama Y., Maruhashi T., Ookawa K., Dai K., and Aokage Y. Impact of admission hyperglycemia and diabetes mellitus on short- and long-term mortality after acute myocardial infarction in the coronary intervention era. Am J Cardiol 99 (2007) 1674-1679
4. Ishihara M., Kojima S., Sakamoto T., Asada Y., Tei C., Kimura K., Miyazaki S., Sonoda M., Tsuchihashi K., Yamagishi M., Ikeda Y., Shirai M., Hiraoka H., Inoue T., Saito F., and Ogawa H. Acute hyperglycemia is associated with adverse outcome after acute myocardial infarction in the coronary intervention era. Am Heart J 150 (2005) 814-820
5. Kuchulakanti P.K., Chu W.W., Torguson R., Ohlmann P., Rha S.W., Clavijo L.C., Kim S.W., Bui A., Gevorkian N., Xue Z., Smith K., Fournadjieva J., Suddath W.O., Satler L.F., Pichard A.D., Kent K.M., and Waksman R. Correlates and long-term outcomes of angiographically proven stent thrombosis with sirolimus- and paclitaxel-eluting stents. Circulation 113 (2006) 1108-1113
6. Smith Jr. S.C., Feldman T.E., Hirshfeld Jr. J.W., Jacobs A.K., Kern M.J., King III S.B., Morrison D.A., O'Neill W.W., Schaff H.V., Whitlow P.L., Williams D.O., Antman E.M., Smith Jr. S.C., Adams C.D., Anderson J.L., Faxon D.P., Fuster V., Halperin J.L., Hiratzka L.F., Hunt S.A., Jacobs A.K., Nishimura R., Ornato J.P., Page R.L., and Riegel B. ACC/AHA/SCAI 2005 guideline update for percutaneous coronary intervention-summary article: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/SCAI writing committee to update the 2001 guidelines for percutaneous coronary intervention). J Am Coll Cardiol 47 (2006) 216-235
7. Thygesen K., Alpert J.S., and White H.D. Universal definition of myocardial infarction. J Am Coll Cardiol 50 (2007) 2173-2195
8. Mazeika P., Prasad N., Bui S., and Seidelin P.H. Predictors of angiographic restenosis after coronary intervention in patients with diabetes mellitus. Am Heart J 145 (2003) 1013-1021
9. Hasdai D., Rizza R.A., Grill D.E., Scott C.G., Garratt K.N., and Holmes Jr. D.R. Glycemic control and outcome of diabetic patients after successful percutaneous coronary revascularization. Am Heart J 141 (2001) 117-123
10. Kauffman A.B., Delate T., Olson K.L., Cymbala A.A., Hutka K.A., Kasten S.L., and Rasmussen J.R. Relationship between haemoglobin A1C values and recurrent cardiac events: A retrospective, longitudinal cohort study. Clin Drug Invest 28 (2008) 501-507
11. Lindsay J., Sharma A.K., Canos D., Nandalur M., Pinnow E., Apple S., Ruotolo G., Wijetunga M., and Waksman R. Preprocedure hyperglycemia is more strongly associated with restenosis in diabetic patients after percutaneous coronary intervention than is hemoglobin A1C. Cardiovasc Revasc Med 8 (2007) 15-20
12. O'Sullivan C.J., Hynes N., Mahendran B., Andrews E.J., Avalos G., Tawfik S., Lowery A., and Sultan S. Haemoglobin A1c (HbA1C) in non-diabetic and diabetic vascular patients. Is HbA1C an independent risk factor and predictor of adverse outcome?. Eur J Vasc Endovasc Surg 32 (2006) 188-197
13. Fox C.S., Coady S., Sorlie P.D., D'Agostino Sr. R.B., Pencina M.J., Vasan R.S., Meigs J.B., Levy D., and Savage P.J. Increasing cardiovascular disease burden due to diabetes mellitus: the Framingham Heart Study. Circulation 115 (2007) 1544-1550
14. Buse J.B., Ginsberg H.N., Bakris G.L., Clark N.G., Costa F., Eckel R., Fonseca V., Gerstein H.C., Grundy S., Nesto R.W., Pignone M.P., Plutzky J., Porte D., Redberg R., Stitzel K.F., and Stone N.J. Primary prevention of cardiovascular diseases in people with diabetes mellitus: a scientific statement from the American Heart Association and the American Diabetes Association. Circulation 115 (2007) 114-126
15. UK Prospective Diabetes Study (UKPDS) Group. Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). Lancet 352 (1998) 854-865
16. UK Prospective Diabetes Study (UKPDS) Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 352 (1998) 837-853
17. Gerstein H.C., Miller M.E., Byington R.P., Goff Jr. D.C., Bigger J.T., Buse J.B., Cushman W.C., Genuth S., Ismail-Beigi F., Grimm Jr. R.H., Probstfield J.L., Simons-Morton D.G., and Friedewald W.T. Effects of intensive glucose lowering in type 2 diabetes. N Engl J Med 358 (2008) 2545-2559
18. Ohkubo Y., Kishikawa H., Araki E., Miyata T., Isami S., Motoyoshi S., Kojima Y., Furuyoshi N., and Shichiri M. Intensive insulin therapy prevents the progression of diabetic microvascular complications in Japanese patients with non-insulin-dependent diabetes mellitus: a randomized prospective 6-year study. Diabetes Res Clin Pract 28 (1995) 103-117
19. Lev E.I., Patel R.T., Maresh K.J., Guthikonda S., Granada J., DeLao T., Bray P.F., and Kleiman N.S. Aspirin and clopidogrel drug response in patients undergoing percutaneous coronary intervention: the role of dual drug resistance. J Am Coll Cardiol 47 (2006) 27-33
20. Shichiri M., Kishikawa H., Ohkubo Y., and Wake N. Long-term results of the Kumamoto study on optimal diabetes control in type 2 diabetic patients. Diabetes Care 23 suppl 2 (2000) B21-B29
21. Abraira C., Colwell J., Nuttall F., Sawin C.T., Henderson W., Comstock J.P., Emanuele N.V., Levin S.R., Pacold I., and Lee H.S. Cardiovascular events and correlates in the Veterans Affairs Diabetes Feasibility Trial. Veterans Affairs cooperative study on glycemic control and complications in type II diabetes. Arch Intern Med 157 (1997) 181-188
22. Holman R.R., Paul S.K., Bethel M.A., Matthews D.R., and Neil H.A. 10-Year follow-up of intensive glucose control in type 2 diabetes. N Engl J Med 359 (2008) 1577-1589
23. Malmberg K., Ryden L., Wedel H., Birkeland K., Bootsma A., Dickstein K., Efendic S., Fisher M., Hamsten A., Herlitz J., Hildebrandt P., MacLeod K., Laakso M., Torp-Pedersen C., and Waldenstrom A. Intense metabolic control by means of insulin in patients with diabetes mellitus and acute myocardial infarction (DIGAMI 2): effects on mortality and morbidity. Eur Heart J 26 (2005) 650-661
24. Mellbin L.G., Malmberg K., Norhammar A., Wedel H., and Ryden L. The impact of glucose lowering treatment on long-term prognosis in patients with type 2 diabetes and myocardial infarction: a report from the DIGAMI 2 trial. Eur Heart J 29 (2008) 166-176